Tag: clinical trials
Although the trial showed that relapse is more likely if you reduce antipsychotic medication, it did not show that relapse is inevitable.
An interview with John Read and Irving Kirsch to discuss their paper which calls to prohibit ECT. This is because the negative effects of ECT are so strong, the evidence supporting it is so weak (especially in the long-term and beyond the improvement due to placebo) and there are other means of addressing the difficulties that the person is struggling with.
An interview with Professor John Read who joins us to discuss the UK licensing of esketamine nasal spray (Spravato) for so-called ‘Treatment Resistant Depression’. John led a group of 12 academics and professionals who wrote to the UK regulator expressing concerns.
My heart goes out to anyone experiencing withdrawal but especially those surrounded by unsupportive judgemental people, and those who are so ill they can’t work and are struggling to navigate a heartless and cynical ‘benefits’ system. Denial and minimisation make it even more difficult for people to access help, support or seek understanding. Their only crime is to have experienced difficulty from a prescribed treatment, yet they are treated as medical pariahs.
We suggest there now ought to be an important debate as to whether criticism of CBT for psychosis has led to people who are distressed by experiences, such as hearing voices or other experiences of psychosis, being less likely to have been offered an effective intervention as a direct consequence.
12Page 1 of 2